Opportunistic Screening for Pancreatic Cancer - Multimodal AI Fusion of CT Imaging and Radiology Reports

Explore a cutting-edge medical AI lecture that presents groundbreaking research on early pancreatic cancer detection through multimodal artificial intelligence approaches. Learn how researchers are developing opportunistic screening methods that combine CT imaging with radiology reports to identify pancreatic ductal adenocarcinoma (PDAC) before traditional diagnostic methods. Discover the innovative multimodal survival model that integrates quantitative radiomics features with contextual information from clinical narratives using deep language embeddings, achieving superior prognostic accuracy compared to single-modality approaches. Understand how this fusion of text and imaging data enables improved risk stratification across multiple patient cohorts and its potential to revolutionize early detection of one of the most lethal cancers. Gain insights into the clinical translation challenges and opportunities in developing digital biomarkers for pancreatic cancer, presented by Dr. David Le, a postdoctoral fellow at Mayo Clinic whose research bridges medical imaging, AI, and precision medicine. The presentation includes detailed methodology, validation results across internal and external cohorts, and discussion of how these advances could guide clinical decision-making and enable earlier interventions for high-risk patients.